# SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries.

> **NCT05006950** · PHASE1 · TERMINATED · sponsor: **Stryker Endoscopy** · enrollment: 50 (actual)

## Conditions studied

- Cholecystitis

## Interventions

- **DEVICE:** Stryker1688 Fluorescence imaging system

## Key facts

- **NCT ID:** NCT05006950
- **Lead sponsor:** Stryker Endoscopy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-28
- **Primary completion:** 2022-02-08
- **Final completion:** 2022-09-07
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Business/strategic reasons and low accrual rate
- **Last updated:** 2022-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05006950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05006950, "SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05006950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*